Medicines And Healthcare Products Regulatory Agency (mhra) - Vaccines

Relevant Publications

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia.

Issue Release: 2024

Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial.

Issue Release: 2024

Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises.

Issue Release: 2024

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example.

Issue Release: 2024

Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study.

Issue Release: 2024

Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2.

Issue Release: 2024

Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2.

Issue Release: 2024

Gene therapy for neurotransmitter-related disorders.

Issue Release: 2024

Spontaneous histopathology in New Zealand White rabbits: ten years of control data.

Issue Release: 2024

An observational study on the safety of teprotumumab based on FAERS database.

Issue Release: 2024

Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis.

Issue Release: 2024

The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case Studies.

Issue Release: 2024

Real-World Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM.

Issue Release: 2024

Tibial polyethylene post fractures at ten-years in a bicruciate stabilised (BCS) total knee arthroplasty design.

Issue Release: 2024

Bridging the gap from medical to psychological safety assessment: consensus study in a digital mental health context.

Issue Release: 2024

Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database.

Issue Release: 2024

Good Statistical Practice-development of tailored Good Clinical Practice training for statisticians.

Issue Release: 2024

Statistical Signal Detection Algorithm in Safety Data: A Proprietary Method Compared to Industry Standard Methods.

Issue Release: 2024

Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated.

Issue Release: 2024

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System.

Issue Release: 2024

Which Vaccines Are Safe for Immunocompromised Individuals?

Can the HPV Vaccine Treat Existing HPV Infections?

Is a Booster Dose Necessary?

How Can Communities Be Engaged Effectively?

What Are the Objectives of Vaccine Training Programs?

Why are Vaccines Important in Public Health?

Who Should Get Toxoid Vaccines?

Why is Post Market Surveillance Important?

What is Vaccine Soreness?

What Role Do Immune Markers Play?

Medicines And Healthcare Products Regulatory Agency (mhra) - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics